…
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. It offers digital transformation and cyber security solutions, including artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation to the National Institutes of Health (NIH), Defense Health Agency (DHA), US Army Medical Research and Development Command (MRDC), and US Navy. The company also provides science research and development services and solutions, such as data analytics, testing and evaluation, clinical trials research services, and epidemiology studies to support multiple operating divisions, including NIH and the Center for Disease Control and Prevention, as well as the Military Health System. In addition, it offers systems engineering and integration solutions in the areas of command, control, communications, computers, cyber, intelligence, surveillance, and reconnaissance (C5ISR); modeling, simulation and training, performance-based logistics, and system modernization; and technology-powered health solutions and software engineering on behalf of the US Navy, HHS, VA, and other federal customers. Further, the company holds the trademark, Infinibyte, for cloud-based solution. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
DLH Holdings Corp provides professional services and technology solutions to U.S. federal, state and commercial customers, focusing on health and human services, program operations and IT. Long-term growth may be supported by government healthcare and social program spending, contract renewals and selective acquisitions, while investors may value its contract-based revenue and established agency relationships.
Key risks include reliance on competitively awarded government contracts with customer concentration, exposure to federal and state budget and appropriation cycles, and pressure on margins from contract pricing or execution.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | 1.75M | 7.75M | 0.82M | 31.06M | 13.44M |
| Net income | 1.36M | 7.40M | 1.46M | 23.29M | 10.14M |
| Selling general administrative | 31.20M | 35.54M | 39.53M | 31.34M | 26.14M |
| Gross profit | 65.16M | 77.49M | 79.86M | 72.29M | 51.48M |
| Reconciled depreciation | 17.18M | 17.05M | 15.56M | 7.67M | 8.12M |
| Ebit | 15.12M | 23.10M | 24.76M | 33.28M | 17.22M |
| Ebitda | 32.29M | 40.15M | 40.33M | 40.94M | 25.34M |
| Depreciation and amortization | 17.18M | 17.05M | 15.56M | 7.67M | 8.12M |
| Non operating income net other | - | - | - | -2.21M | -3.78M |
| Operating income | 16.79M | 24.90M | 17.09M | 33.28M | 17.22M |
| Other operating expenses | 327.71M | 371.04M | 351.11M | 361.89M | 228.87M |
| Interest expense | 15.10M | 17.19M | 16.27M | 2.21M | 3.78M |
| Tax provision | 0.39M | 0.35M | -0.64M | 7.78M | 3.29M |
| Interest income | 0.07M | 0.04M | 0.06M | - | - |
| Net interest income | -15.03M | -17.15M | -16.27M | -2.21M | -3.78M |
| Income tax expense | 0.39M | 0.35M | -0.64M | 7.78M | 3.29M |
| Total revenue | 344.50M | 395.94M | 375.87M | 395.17M | 246.09M |
| Total operating expenses | 48.38M | 52.59M | 55.09M | 39.01M | 34.26M |
| Cost of revenue | 279.33M | 318.45M | 296.02M | 322.89M | 194.61M |
| Total other income expense net | -15.03M | -17.15M | -7.67M | -2.21M | -3.78M |
| Net income from continuing ops | 1.36M | 7.40M | 1.46M | 23.29M | 10.14M |
| Net income applicable to common shares | - | - | - | 23.29M | 10.14M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 290.66M | 314.38M | 339.84M | 169.01M | 197.17M |
| Intangible assets | 91.86M | 108.32M | 124.78M | 40.88M | 47.47M |
| Other current assets | 2.91M | 1.86M | 3.07M | 2.88M | 4.26M |
| Total liab | 177.71M | 204.25M | 237.40M | 76.95M | 131.56M |
| Total stockholder equity | 112.96M | 110.13M | 102.44M | 92.06M | 65.61M |
| Other current liab | 19.05M | 24.13M | 0.64M | 9.44M | 9.12M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Retained earnings | 11.21M | 9.85M | 2.45M | 0.99M | -22.30M |
| Other liab | - | - | - | 1.53M | 1.18M |
| Good will | 138.16M | 138.16M | 138.16M | 65.64M | 65.64M |
| Other assets | - | - | - | 0.33M | 0.46M |
| Cash | 0.12M | 0.34M | 0.21M | 0.23M | 24.05M |
| Total current liabilities | 42.67M | 53.24M | 64.79M | 38.54M | 66.38M |
| Current deferred revenue | - | - | 13.79M | - | 22.27M |
| Net debt | 144.85M | 164.47M | 191.49M | 38.88M | 42.22M |
| Short term debt | 10.98M | 14.71M | 20.65M | 2.23M | 2.26M |
| Short long term debt | 8.07M | 12.06M | 17.19M | - | - |
| Short long term debt total | 144.97M | 164.81M | 191.71M | 39.11M | 66.27M |
| Other stockholder equity | 101.73M | 100.27M | 99.97M | 91.06M | 87.89M |
| Property plant equipment | - | - | - | 18.55M | 1.91M |
| Total current assets | 42.54M | 52.96M | 62.40M | 43.60M | 61.76M |
| Net tangible assets | - | - | - | -14.47M | -0.04M |
| Net receivables | 39.51M | 50.76M | 59.12M | 40.50M | 33.45M |
| Long term debt | 119.97M | 137.32M | 155.15M | 20.42M | 44.64M |
| Accounts payable | 12.30M | 13.42M | 29.70M | 26.86M | 32.72M |
| Common stock total equity | - | - | - | 0.01M | 0.01M |
| Retained earnings total equity | - | - | - | 0.99M | -22.30M |
| Non currrent assets other | 0.12M | 0.19M | 0.19M | 0.33M | 0.46M |
| Non current assets total | 248.13M | 261.42M | 277.44M | 125.41M | 135.41M |
| Capital lease obligations | 16.94M | 15.44M | 19.37M | 18.70M | 21.64M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Investments | - | -0.84M | -181.20M | -0.87M | -0.04M |
| Change to liabilities | - | - | - | -28.13M | 3.14M |
| Total cashflows from investing activities | -0.24M | -0.84M | - | -0.87M | -0.04M |
| Net borrowings | -22.99M | -24.80M | - | -24.75M | -23.29M |
| Total cash from financing activities | -23.19M | -26.40M | 150.15M | -24.19M | -22.93M |
| Change to operating activities | - | - | - | 1.84M | -1.77M |
| Net income | 1.36M | 7.40M | 1.46M | 23.29M | 10.14M |
| Change in cash | -0.22M | 0.13M | -0.01M | -23.82M | 22.69M |
| Begin period cash flow | 0.34M | 0.21M | 0.23M | 24.05M | 1.36M |
| End period cash flow | 0.12M | 0.34M | 0.21M | 0.23M | 24.05M |
| Total cash from operating activities | 23.22M | 27.37M | 31.03M | 1.24M | 45.66M |
| Issuance of capital stock | - | - | - | - | 0.37M |
| Depreciation | 17.18M | 17.05M | 15.56M | 7.67M | 8.12M |
| Other cashflows from investing activities | - | -0.84M | - | - | 0.06M |
| Dividends paid | - | - | - | 0.28M | - |
| Change to inventory | - | - | -1.72M | - | -2.25M |
| Change to account receivables | 11.46M | 9.27M | 6.84M | -7.05M | -0.91M |
| Sale purchase of stock | - | - | -0.65M | -0.28M | 0.37M |
| Other cashflows from financing activities | - | -1.86M | 364.95M | 17.28M | -0.04M |
| Change to netincome | - | - | - | 2.97M | 2.87M |
| Capital expenditures | 0.24M | 0.84M | 0.62M | 0.87M | 0.10M |
| Change receivables | - | - | - | -7.05M | -0.91M |
| Cash flows other operating | - | - | - | -20.89M | 21.51M |
| Cash and cash equivalents changes | - | - | - | -23.82M | 22.69M |
| Change in working capital | 3.17M | 2.35M | 6.84M | -33.34M | 23.74M |
| Stock based compensation | 1.46M | 1.90M | 1.92M | 2.61M | 1.66M |
| Other non cash items | 1.74M | 1.84M | 9.86M | 0.66M | 0.79M |
| Free cash flow | 22.98M | 26.53M | 30.41M | 0.37M | 45.56M |
Sector: Industrials Industry: Specialty Business Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DLHC DLH Holdings Corp |
-0.12 3.30% |
3.52 | - | 17.45 | 0.27 | 0.82 | 0.75 | 8.60 |
| CTAS Cintas Corporation |
1.98 0.88% |
227.26 | 37.19 | 33.11 | 6.39 | 14.93 | 6.73 | 24.37 |
| RELX Relx PLC ADR |
0.20 0.50% |
40.11 | 20.25 | 16.16 | 6.12 | 37.10 | 5.55 | 14.13 |
| RLXXF Relx PLC |
0.20 0.50% |
40.00 | 20.12 | 15.38 | 6.08 | 35.32 | 5.43 | 13.82 |
| TRI Thomson Reuters Corporation Common Shares |
0.42 0.39% |
108.83 | 27.00 | 20.92 | 5.68 | 4.12 | 6.20 | 14.50 |
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. It offers digital transformation and cyber security solutions, including artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation to the National Institutes of Health (NIH), Defense Health Agency (DHA), US Army Medical Research and Development Command (MRDC), and US Navy. The company also provides science research and development services and solutions, such as data analytics, testing and evaluation, clinical trials research services, and epidemiology studies to support multiple operating divisions, including NIH and the Center for Disease Control and Prevention, as well as the Military Health System. In addition, it offers systems engineering and integration solutions in the areas of command, control, communications, computers, cyber, intelligence, surveillance, and reconnaissance (C5ISR); modeling, simulation and training, performance-based logistics, and system modernization; and technology-powered health solutions and software engineering on behalf of the US Navy, HHS, VA, and other federal customers. Further, the company holds the trademark, Infinibyte, for cloud-based solution. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Zachary C. Parker | Pres, CEO & Director | 1957 |
| Ms. Kathryn M. JohnBull | CFO & Treasurer | 1959 |
| Ms. Jacqueline S. Everett | Chief Growth Officer | 1962 |
| Ms. Helene Loraine Fisher M.A. | Pres of Danya International LLC and Mission Services & Solutions Operating Unit | 1964 |
| Ms. Jeanine M. Christian | Pres of Social & Scientific Systems Inc and Public Health & Scientific Research Operating Unit | 1968 |
| Dr. Sandra Halverson M.P.H., Ph.D. | Chief Scientist | NA |
| Mr. John F. Armstrong FACHE, MBA | Exec. VP of Corp. Devel. | 1949 |
| Mr. Galeel Maliek Ferebee | Chief HR Officer | 1979 |
| Ms. Denise Ciotti | Sr. VP | NA |
| Mr. Victor J. DiGioia Esq. | Sec. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.